DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Syncom Formulations (India) Limited — Change in Management

NSE 1 hr ago·1 Oct 2026, 2:35 pm

Syncom Formu (I)

Syncom Formulations (India) Limited has informed the stock exchanges about a change in its management structure. This development involves the appointment of a new Chief Executive Officer, marking a shift in the company's leadership team.

For investors, this news is significant as it signals a potential transition in the company's strategic direction and operational focus. New leadership often brings fresh perspectives, which could impact the company's future growth plans and decision-making processes.

Investors should monitor the new management's initial actions and strategic announcements. It is important to assess whether the leadership change aligns with the company's long-term goals and how it might affect the stock's performance in the coming quarters.